Zyprexa Suits Weigh Heavily On Eli Lilly's Future

Law360, New York (July 13, 2007, 12:00 AM EDT) -- Though pharmaceutical giant Eli Lilly & Co. recently settled a slew of claims related to its blockbuster schizophrenia drug Zyprexa, its battle with consumers who allege the drug company did not warn them about Zyprexa's side effects is far from over.

Zyprexa, a brand name version of olanzapine, is an atypical antipsychotic prescription medication used to treat symptoms of various psychiatric conditions, such as schizophrenia and bipolar disorder.

The drug quickly became a huge earner for Eli Lilly—in 2004, customers around the world bought $4.4 billion...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.